PROC Rasio cepet Procaps Group S.A.

Procaps Group S.A. (PROC) generates revenue through B2B contracts for softgel capsule production, ensuring high margins and a steady cash flow. This chart shows the asset value is fixed at 0.00. Ownership of the unique Softgel technology makes the company an indispensable link in the global pharmaceutical supply chain. However, debts within Latin American divisions and reporting delays necessitate strict oversight, as operating profit is approaching a critical minimum.

As a CDMO leader in softgel production for global pharma behemoths, Procaps Group S.A. (PROC) relies on high asset turnover. The quick ratio excludes inventory, assessing the company's ability to settle short-term liabilities using only cash and accounts receivable. The stability of this curve confirms the business's solvency without relying on the sale of goods. Excessive growth in this metric would indicate inefficient capital utilization.